دورية أكاديمية
MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide
| العنوان: | MGMT Promoter Methylation Status Independently Predicts Overall Survival in Anaplastic Astrocytoma in NRG Oncology/RTOG 9813: A Phase 3 Trial of Radiation Plus Nitrosourea Versus Radiation Plus Temozolomide |
|---|---|
| المؤلفون: | Bell, E.H., Won, M., Chang, S.M., Cairncross, G., Gilbert, M., Bahary, J.P., Dolinskas, C., Aldape, K., McElroy, J., Fleming, J., Ashby, L., Shih, H.A., Hunter, G.K., Yung, W.A., Howard, S.P., Belanger, K., Siker, M.L., Kavanagh, B.D., Chen, Y., Chakravarti, A. |
| المصدر: | International Journal of Radiation Oncology*Biology*Physics ; volume 99, issue 2, page S99-S100 ; ISSN 0360-3016 |
| بيانات النشر: | Elsevier BV |
| سنة النشر: | 2017 |
| المجموعة: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| مصطلحات موضوعية: | Cancer Research, Radiology, Nuclear Medicine and imaging, Oncology, Radiation |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| DOI: | 10.1016/j.ijrobp.2017.06.238 |
| الإتاحة: | https://doi.org/10.1016/j.ijrobp.2017.06.238Test https://api.elsevier.com/content/article/PII:S0360301617312889?httpAccept=text/xmlTest https://api.elsevier.com/content/article/PII:S0360301617312889?httpAccept=text/plainTest |
| حقوق: | https://www.elsevier.com/tdm/userlicense/1.0Test/ |
| رقم الانضمام: | edsbas.21AD95BC |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ijrobp.2017.06.238 |
|---|